Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Results
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Study randomisation

Posted on August 10, 2016December 19, 2018 by Wendy van Hemmen

You are required to login to view this page.




Lost your password?

This entry was posted in members. Bookmark the permalink.

Post navigation

← How Genetic testing can be used to personalized drug prescriptions and dosages
David Haerry joins U-PGx advisory board →

Recent Posts

  • U-PGx Personalized Medicine Symposium
  • bio.logis receives the E-Health Award Hessen 2021
  • 7th U-PGx Personalized Medicine Day
  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
  • Cathelijne van der Wouden obtains PhD degree in pharmacogenetics
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.